Form 4 for CME CME Group
Accepted 2025-03-18 00:00:00 ET · period of report 2025-03-15 · accession 0001156375-25-000048 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-18 | 2025-03-15 | CME | Winkler Julie | Sr MD Chief Commercial Off | A - Grant | $258.68 | +3,668 | 25.6K | +17% | +$948.8K | |
| 2025-03-18 | 2025-03-15 | CME | Winkler Julie | Sr MD Chief Commercial Off | F - Tax | $258.68 | -1,625 | 23.9K | -6% | -$420.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock Class A | 2025-03-15 | A | A | 3,668 | $258.68 | 25,553 | D | — | — | (F1) For the PSAs granted in September 2021: Represents shares earned from a 2021 performance share award based on the company's achievement of total shareholder return relative to the S&P 500 measured over 2022-2024. |
| 2 | Common | Common Stock Class A | 2025-03-15 | F | D | 1,625 | $258.68 | 23,928 | D | — | — | (F2) Ms. Winkler surrendered shares to the Company in order to fulfill tax withholding obligations in connection with the receipt of the performance share award. |